Metraipolis › archive › dc_ea2d0beec9df

Dysregulated FGFR3 signaling alters the immune landscape in bladder cancer and presents therapeutic possibilities in an agent-based model — Europe PMC PMID:38515743

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/38515743
DOI
10.3389/fimmu.2024.1358019
License (as archived)
solo-consultazione
Archived
2026-10-07T18:37:29.155Z
SHA-256 of the archived text
6617c49ad6973f5071cdf0f88a9bb6ecde87340dd146d209e9c07fb9afcecc40
Stable URL of this page
https://metraipolis.com/documento/dc_ea2d0beec9df

How to cite

Dysregulated FGFR3 signaling alters the immune landscape in bladder cancer and presents therapeutic possibilities in an agent-based model — Europe PMC PMID:38515743 — Europe PMC (en), https://europepmc.org/article/MED/38515743 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ea2d0beec9df (Metraipolis archive dc_ea2d0beec9df, sha256 6617c49ad6973f5071cdf0f88a9bb6ecde87340dd146d209e9c07fb9afcecc40)
BibTeX
@misc{dcea2d0beec9df,
  title = {Dysregulated FGFR3 signaling alters the immune landscape in bladder cancer and presents therapeutic possibilities in an agent-based model — Europe PMC PMID:38515743},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/38515743},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ea2d0beec9df; sha256 6617c49ad6973f5071cdf0f88a9bb6ecde87340dd146d209e9c07fb9afcecc40},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/38515743. Agents can read the archived copy with the MCP tool read_document.